Summary
Hims & Hers announced they are scrapping plans to sell a compounded version of the weight loss drug Wegovy after federal regulators vowed to take action against the telehealth provider.
Source: New York Post
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
